Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

25th Anniversary Commentaries

Citations 1-22 of 22 total displayed.

Commentary
Pre- or Postoperative Therapy for Wilms’ Tumor?
Giulio J. D'Angio
J. Clin. Oncol. 2008; 26: 4055-4057. [Full text] [PDF]  

Commentary
Pre- or Postoperative Therapy for Wilms’ Tumor?
Giulio J. D'Angio
J. Clin. Oncol. 2008; 26: 4055-4057. [Full text] [PDF]  

Commentary
Prognostic Factors in Metastatic Breast Cancer: Successes and Challenges Toward Individualized Therapy
Eleni Andreopoulou and Gabriel N. Hortobagyi
J. Clin. Oncol. 2008; 26: 3660-3662. [Full text] [PDF]  

Commentary
The Long Road to a Cure for Acute Myelocytic Leukemia: From Intensity to Specificity
William P. Vaughan and Judith E. Karp
J. Clin. Oncol. 2008; 26: 3475-3477. [Full text] [PDF]  

Commentary
Chemotherapy for the Treatment of Children and Adolescents With Malignant Germ Cell Tumors
Daniel M. Green
J. Clin. Oncol. 2008; 26: 3297-3298. [Full text] [PDF]  

Commentary
Lessons From a Time Capsule: Evolution, Not Revolution, in Therapy for Advanced Non–Small-Cell Lung Cancer
Mark R. Green
J. Clin. Oncol. 2008; 26: 3112-3113. [Full text] [PDF]  

Commentary
Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma: Yesterday, Today, and Tomorrow
Frederick R. Appelbaum
J. Clin. Oncol. 2008; 26: 2927-2929. [Full text] [PDF]  

Commentary
Hairy Cell Leukemia: Treatment Successes in the Past 25 Years
Harvey M. Golomb
J. Clin. Oncol. 2008; 26: 2607-2609. [Full text] [PDF]  

Commentary
Chemotherapy for Advanced Prostate Cancer: 25 Years Later
Christopher J. Logothetis and Randall Millikan
J. Clin. Oncol. 2008; 26: 2423-2424. [Full text] [PDF]  

Commentary
High-Dose Melphalan and the Development of Hematopoietic Stem-Cell Transplantation: 25 Years Later
Hillard M. Lazarus, Gordon L. Phillips, Roger H. Herzig, David D. Hurd, Steven N. Wolff, and Geoffrey P. Herzig
J. Clin. Oncol. 2008; 26: 2240-2243. [Full text] [PDF]  

Commentary
Evolution of Knowledge Related to Breast Cancer Heterogeneity: A 25-Year Retrospective
Bernard Fisher, Carol K. Redmond, and Edwin R. Fisher
J. Clin. Oncol. 2008; 26: 2068-2071. [Full text] [PDF]  

Commentary
What Constitutes "Improved Prognosis"?
George P. Canellos
J. Clin. Oncol. 2008; 26: 1913-1914. [Full text] [PDF]  

Commentary
Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
Robert K. Oldham and Robert O. Dillman
J. Clin. Oncol. 2008; 26: 1774-1777. [Full text] [PDF]  

Commentary
Breaking the Cure Barrier 25 Years Later
James F. Holland
J. Clin. Oncol. 2008; 26: 1575. [Full text] [PDF]  

Commentary
Evolution of Breast-Conserving Therapy for Localized Breast Cancer
Stuart J. Schnitt and Jay R. Harris
J. Clin. Oncol. 2008; 26: 1395-1396. [Full text] [PDF]  

Commentary
Immunophenotyping of Chronic Lymphoid Leukemias
Robert O. Dillman
J. Clin. Oncol. 2008; 26: 1193-1194. [Full text] [PDF]  

Commentary
Tailoring Treatment to Prognosis for Childhood Localized Non-Hodgkin's Lymphoma
Sharon B. Murphy
J. Clin. Oncol. 2008; 26: 1020-1021. [Full text] [PDF]  

Commentary
Stem-Cell Biology and Cancer Therapy: The More Things Change...
Samuel Hellman, Leslie Botnick, and Peter Mauch
J. Clin. Oncol. 2008; 26: 821-822. [Full text] [PDF]  

Commentary
Preoperative Therapy in Invasive Breast Cancer: Reviewing the State of the Science and Exploring New Research Directions
Julie R. Gralow, Jo Anne Zujewski, and Eric Winer
J. Clin. Oncol. 2008; 26: 696-697. [Full text] [PDF]  

Commentary
Follicular Lymphoma Revisited
Saul A. Rosenberg
J. Clin. Oncol. 2008; 26: 515-516. [Full text] [PDF]  

Commentary
Lessons From the Initial Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil Studies in Operable Breast Cancer
Gianni Bonadonna, Pinuccia Valagussa, and Umberto Veronesi
J. Clin. Oncol. 2008; 26: 342-344. [Full text] [PDF]  

Commentary
Predicting Outcomes in Metastatic Melanoma
Charles M. Balch and Seng-jaw Soong
J. Clin. Oncol. 2008; 26: 168-169. [Full text] [PDF]  

Commentary
Reflections on Medical Oncology: 25 Years of Clinical Trials—Where Have We Come and Where Are We Going?
Christopher M. Booth and Ian Tannock
J. Clin. Oncol. 2008; 26: 6-8. [Full text] [PDF]  

* Sign up for Collection Alerts

* Collected Resources Home

* Related collections:
 25th Anniversary Commentaries
 Art of Oncology
 Biostatistics and Clinical Trial Methodology
 Bone Marrow Transplantation
 Breast Cancer
 Cancer-Related Complications
 Clinical Guidelines
 Diagnosis and Staging
 Endocrine System Cancer
 Epidemiology, Cancer Prevention, and Control
 Gastrointestinal Cancer
 Genitourinary Cancer
 Gynecologic Cancer
 Head and Neck Cancer
 Health Services Research
 Hematologic Malignancies
 JCO Translations
 Melanoma
 Neurooncology
 Non-Melanoma Skin Cancer
 Patient and Survivor Care
 Pediatric Oncology
 Phase I and Clinical Pharmacology
 Radiation Oncology
 Sarcomas
 Surgical Oncology
 Thoracic Oncology
 Translational Oncology
 Treatment-Related Complications
 Tumor Imaging
 Unknown Primary Site and Rare Cancers

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online